INKEF Capital

INKEF Capital INKEF Capital, founded in 2010 in Amsterdam, backs promising early-stage European companies with deep tech explicitly included in its investment thesis. The firm has made 51 investments, with top sectors being life sciences (22 investments) and enterprise applications (18). Preferred stages are seed and Series A, though the team may consider exceptional opportunities outside that range. The investment focus splits into two tracks. In healthcare, INKEF targets therapeutics, digital